Pharmacodynamics and chiral pharmacokinetics of carprofen in calves

British Veterinary Journal

Volumn 152, Issue 2, 1996, Pages 183-198

  Delatour, P ^a,c   Foot, R ^a,b   Foster, A P ^a   Baggot, D ^a   Lees, P ^a  

^a VETAGRO SUP   (France)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c IRISH EQUINE CENTRE   (Ireland)

Author keywords

Calves; Carprofen; Chiral; Enantiomers; Pharmacokinetics

Indexed keywords

CARPROFEN; CARRAGEENAN; DEXTRAN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; THROMBOXANE B2;

ANIMAL EXPERIMENT; ARTICLE; CATTLE; CHIRALITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENANTIOMER; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACODYNAMICS; RACEMIC MIXTURE; TEMPERATURE;

EID: 0029915855     PISSN: 00071935     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0007-1935(96)80073-X     Document Type: Article

References (30)

1. ADAMS, S. S., BRESFOFF, P. & MASON, C. G. (1976). Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-) isomer. Journal of Pharmacy and Pharmacology 28, 256-7.
2. ArrLETON, I., TOMLINSON, A. & WiLLouciiBV, D. A. (1994). Inducible cyclo-oxygenase (COX2): a safer therapeutic target? British Journal ofRlmimatology 33, 410-92.
3. BRUNE, K., GEISSI.INGER, G. & MENZEL-SOGLOWCK, S. L. (1992). Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology. Journal of Clinical Pharmacology 32, 944-52.
4. GMDWELL, J., HUTT, A. J. & FOURNEDGIGLEUX, S. (1988). The metabolic chiral inversion and dispositional enantioselectivity of the 2-ar)'lpropionic acids and their biological consequences. Biochemical Pharmacology 37, 105-14.
5. DELATOUR, P., BENOIT, E., BOURDIX, M., GOBRON, M. & MOWAN, F. (1993). Enantiosélectivé comparée de la dispositon de deux anti-inflammatoires non steroïdiens, le kétoprofène et le carprofène, chez l'homme et l'animal. Bulletin Académie Nationale de Médecine 177, 515-27.
6. DELATOUR, P., BENOIT, E. & SORACI, A. (1994). Drug chirality: its significance in veterinary pharmacology and therapeutics. In Proceedings of the 6th International Congress of the European Association for Veterinary Pharmacology and Toxicology, pp. 6-9. Oxford: Blackwell Scientific Publications.
7. EVANS, A. M. (1992). Enantiosélectivé pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs. European Journal of Clinical Pharmacology 42, 237-56.
8. FOSTER, R. T. &JAMALI, F. (1987). High performance liquid chromatography assay of ketoprofen enantiomers in human plasma and urine. Journal of Chromatography 416, 388-93.
9. GAUT, Z. W., BARUTII, L., RANDALL, L. O., ASIILEV, C. & PAUI.SRUD, J. R. (1975). Stereoisomeric relationships among anti-infiammatory activity, inhibition of platelet aggregation and inhibition of prostaglandin synthetase. Prostaglandins 10, 59-66.
10. GRASER, T. A., JORDAN, J.-C., KARFF, M. & HOI.CK, M. (1991). Determination of carprofen enantiomers: application to biological fluids of target species. Acta Vetennaria Scandinavica Supplement 74, 247-8.
11. HIGGINS, A. J. & LEES, P. (1984). Arachidonic acid metabolites in carrageenin-induced equine inflammatory exudate. Journal of Veterinary Pharmacology and Therapeutics 7, 65-72.
12. KUZUMA, S., MATSUMOTO, N., KOMETANI, T. & KAWAI, K. (1974). Biological activities of optical isomers of 6-chloro-5-cyclohexyIindan-l-carboxyIic acid (TAI-248:anti-inflammatory agents). Japanese Journal of Pharmacology 24, 695-705.
13. LEES, P., EWINS, C. P. TAYI.OR, J. B. O. & SEDGWICK, A. D. (1987). Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. British Veterinary Journal 143, 462-76.
14. LEES, P., DELATOUR, P., BENOIT, E. & FOSTER, A. P. (1991). Pharmacokinetics of carprofen enantiomers in the horse. Ada Vetennaria Scandinavica Supplement 87, 249-51.
15. LEES, P., McKELiAR, Q. A., MAY, S. A. & LUDWIG, B. M. (1994). Pharmacodynamics and pharmacokinetics of carprofen in the horse. Equine Veterinary Journal 26, 203-8.
16. LOHUIS, J. A. C. M., VAN WERVEN, T., BRAND, A. et al. (1991). Pliarmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. Journal of Veterinary Phannacology and Therapeutics 14, 219-29.
17. LUDWIG, B. M., JORDAN, J-C., RERUN, W. F. & TIIUN, R. (1989). Carprofen in Veterinär)- medicine. 1. Plasma disposition, milk excretion and tolerance of carprofen in milk producing cows. Schweizer Archiv für Tierheilkunde 131, 99-106.
18. MAEDA, M., TANOKA, Y., SUSUKI, T. & NAKAMURA, K. (1977). Pharmacological studies on carprofen a new NSAID in animals. Folia Phannacologicajaponica 73, 757-77.
19. McCoRMACK, K. & BRUNE, K. (1991). Dissociation between the anti-nociceptive and antiinflammatory effects of the non-steroidal anti-inflammatory drugs. A survey of their analgesic efficiency. Dmgs41, 533-47.
20. MC.KEI.IAR, Q. A., PERSON, T., BOGAN, J. A. et al. (1990). Pharmacokinetics, tolerance and serum thromboxane inhibition of carprofen in the dog. Journal of Small Animal Practice 31,443-8.
21. McKELLAR, Q. A., DELATOUR, P. & LEES, P. (1994). Stereospecific pharmacod>-namics and pharmacokinetics of carprofen in the dog. Journal of Veterinary Pharmacology and Therapeutics 17, 447-54.
22. RANDALL, L. O. & BARUTH, H. (1976). Analgesic and anti-inflammatory activity of 6-chloroalpha-methyl-carbazole-2-acetic acid (C-5720). Archives Internationale Phannacodynamie 220,94-114.
23. ScuvrzMANN, U., GL-GEI.MANN', M., Vox CRAXACII, J., LUDWIG, B. M. & REHM, W. F. (1990). Pharmacod>Tiamic evaluation of the peripheral pain inhibition by carprofen and flunixin in the horse. Schweizer Archiv Für Tierheilhunde 132, 497-504.
24. SciiATZMANN, U., GucEL.MA.NN, M., GRAN-ACH, J. et al. (1992). Visceral and peripheral pain detection models in the horse using flunixin and carprofen. In Animal Pain, eds C. E. Short & A. V. Poznak, pp. 411-20. Edinburgh: Churchill Livingston Inc.
25. SORACI, A., BENOIT, E., JAUSSAUD, P., LEES, P. & DELATOUR, P. (1995). Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses. American Journal of Veterinary Kesearch 56, (in press).
26. STRUB, K. M., AEPPLI, L. & MüLLER, R. K. M. (1982). Pharmacological properties of carprofen. European Journal ofWieumalology and Inflammation 5, 478-87.
27. TAMURA, S., KUJUNA, S. & KAWAI, K. (1981). Inhibition of prostaglandin biosynthesis by clidanac and related compounds: structural and conformational requirements for PG synthetase inhibition. Journal ofPhannacy and Pharmacology 33, 29-32.
28. VANE, J. R. & BOTTING, R. M. (1995). New insights into the mode of action of anti-inflammatory drugs. Inflammation Research 44, 1-10.
29. WELSH, E. M., BAXTER, P. & NOLAN, A. M. (1992). Pharmacokinetics of carprofen administered intravenously to sheep. Research in Veterinary Science 53, 264-6.
30. WILLIAMS, K- & LEE, E. C. (1985). Importance of drug cnantiomers in clinical pharmacology. Drugs 30, 333-54.